THC Suppressed Multiple Immune Cell Types in Labs and Animals, but Direct Evidence in Humans Was Missing
A 1998 review found THC suppressed macrophages, T cells, and natural killer cells and decreased resistance to bacterial, viral, and parasitic infections in lab and animal studies, but definitive evidence linking marijuana use to increased infection in humans was unavailable.
Quick Facts
What This Study Found
This review synthesized the evidence on THC and immune function, finding consistent immunosuppressive effects across multiple experimental models.
THC decreased host resistance to bacterial, protozoan, and viral infections in lab and animal studies. The primary immune cells affected were macrophages (first-line defenders), T lymphocytes (adaptive immunity coordinators), and natural killer cells (which target infected and cancerous cells).
However, the review drew an important distinction: definitive data directly linking marijuana use to increased susceptibility to infection in living humans was currently unavailable. The evidence was extrapolated from in vitro and animal studies, which supported the hypothesis that similar effects would occur in humans but had not confirmed it.
Key Numbers
Three major immune cell types affected: macrophages, T lymphocytes, natural killer cells. Three categories of infection with reduced resistance: bacterial, protozoan, viral.
How They Did This
Narrative review of experimental studies examining THC effects on immune function across in vitro models, animal studies, and human data. Covered macrophage, T cell, and NK cell responses and host resistance to various infectious agents.
Why This Research Matters
This review highlighted a persistent gap in cannabis immunology: extensive laboratory evidence of immunosuppression but limited clinical confirmation in humans. This gap remains partially unfilled, making it one of the longest-standing unanswered questions in cannabis research.
The Bigger Picture
The disconnect between strong lab evidence and weak clinical evidence for cannabis immunosuppression may reflect the immune system's redundancy and compensatory mechanisms. In living organisms, suppression of one pathway may be compensated by others, explaining why test-tube findings do not always translate to real-world infections.
What This Study Doesn't Tell Us
The review acknowledged that definitive human data was unavailable. Animal and in vitro models use different doses, routes, and exposure durations than human cannabis use. The THC concentrations used in lab studies often exceed physiological levels.
Questions This Raises
- ?Why has the lab-to-human translation been so difficult to demonstrate?
- ?Does the endocannabinoid system's role in immune regulation complicate simple immunosuppression narratives?
- ?Are immunocompromised populations at genuinely increased risk?
Trust & Context
- Key Stat:
- Definitive data linking marijuana use to increased human infection was unavailable
- Evidence Grade:
- A narrative review synthesizing extensive lab and animal data. Limited by the acknowledged absence of definitive human evidence.
- Study Age:
- Published in 1998. The endocannabinoid system's role in immune regulation has been further characterized since, adding complexity to the simple immunosuppression model.
- Original Title:
- Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.
- Published In:
- Journal of neuroimmunology, 83(1-2), 116-23 (1998)
- Authors:
- Cabral, G A, Dove Pettit, D A
- Database ID:
- RTHC-00064
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does cannabis weaken the immune system?
In lab and animal studies, THC consistently suppressed immune cell function. But as of 1998, definitive evidence that this translates to increased infections in human marijuana users was unavailable.
Which immune cells are affected?
Macrophages (first-line defenders), T lymphocytes (adaptive immunity), and natural killer cells (which target infected and cancerous cells) were the major targets of THC immunosuppression.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- cannabis-and-ibs-gut-health-inflammation
- cannabis-and-crohns-disease-gastroenterology
Cite This Study
https://rethinkthc.com/research/RTHC-00064APA
Cabral, G A; Dove Pettit, D A. (1998). Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.. Journal of neuroimmunology, 83(1-2), 116-23.
MLA
Cabral, G A, et al. "Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.." Journal of neuroimmunology, 1998.
RethinkTHC
RethinkTHC Research Database. "Drugs and immunity: cannabinoids and their role in decreased..." RTHC-00064. Retrieved from https://rethinkthc.com/research/cabral-1998-drugs-and-immunity-cannabinoids
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.